In large clinical trials, #Invokana patients underwent #amputation at twice the normal rate https://t.co/AQR3dcrz99
— The Legal Herald (@LegalHerald) June 20, 2017
from Twitter https://twitter.com/LegalHerald
The Legal Herald
Tuesday 20 June 2017
In large clinical trials, #Invokana patients underwent #amputation at twice the normal rate https://t.co/AQR3dcrz99
from Twitter https://twitter.com/LegalHerald
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment